{
    "title": "Valeant says it will exceed debt repayment target, shares surge",
    "url": "https://www.dailymail.co.uk/wires/reuters/article-4771252/Valeant-cuts-revenue-forecast-makes-progress-debt-repayment.html",
    "date": "2017-08-08",
    "keywords": [
        "debt",
        "company",
        "business",
        "forecast",
        "tuesday",
        "percent",
        "bausch",
        "papa",
        "companys",
        "time",
        "valeant",
        "revenue",
        "year",
        "inc",
        "news",
        "quarter",
        "growth",
        "lomb",
        "salix",
        "helm",
        "april",
        "chief",
        "executive",
        "joseph",
        "regain",
        "investor",
        "confidence",
        "flurry",
        "accounting",
        "pricing",
        "papas",
        "spate",
        "ceo",
        "mike",
        "legacy",
        "pledge",
        "flexibility",
        "future",
        "interview",
        "period",
        "invest",
        "ebitda",
        "money",
        "team",
        "drug",
        "bowel",
        "syndrome",
        "june",
        "drugmaker",
        "cancer",
        "treatment",
        "unit",
        "dendreon",
        "share",
        "analyst",
        "estimate",
        "thomson",
        "xifaxan",
        "line",
        "interest",
        "tax",
        "depreciation",
        "amortization",
        "monday",
        "fda",
        "eye",
        "drop",
        "facility",
        "tampa",
        "florida",
        "laval",
        "morning",
        "trading",
        "reporting",
        "grover",
        "bengaluru",
        "michael",
        "erman",
        "york",
        "editing",
        "chakrabarty"
    ],
    "category": [
        "wires",
        "reuters"
    ]
}